News
In an interview over the weekend, FDA Commissioner Dr. Marty Makary came across as “scientifically-grounded level-headed with regards to ...
As previously reported, Wolfe Research analyst Andy Chen upgraded Intellia Therapeutics (NTLA) to Outperform from Peer Perform with a $21 price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback